Copertina

Synergistic interplay of morphology and metabolic activity rule response to CAR-T cells in B-cell lymphomas

Fuente: arXiv

Salvato in:

Dettagli Bibliografici
Autori principali:	Chen, Yifan, Sabir, Soukaina, Kuttler, Christina, Belmonte-Beitia, Juan, Mártínez-Rubio, Alvaro, Martín-Martín, Lourdes, López-Corral, Lucía, Martín-Sancho, Alejandro, Salazar, J. Cristobal Cañadas, Montes-Fuentes, Carlos, Tamayo-Alonso, M. Pilar, Cedillo, Angel, Balsalobre, Pascual, Barba, Pere, Pérez-Martínez, Antonio, Pérez-García, Víctor M.
Natura:	Preprint
Pubblicazione:	2025
Soggetti:	Populations and Evolution
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Understanding the role of B-cells in CAR T-cell therapy in leukemia through a mathematical model
di: Serrano, Sergio, et al.
Pubblicazione: (2024)

A mathematical model of CAR-T cell therapy in combination with chemotherapy for malignant gliomas
di: Sinelshchikov, Dmitry, et al.
Pubblicazione: (2025)

Mathematical model of CAR-T-cell therapy for a B-cell Lymphoma lymph node
di: Sabir, Soukaina, et al.
Pubblicazione: (2024)

Geometric immunosuppression in CAR-T cell treatment: Insights from mathematical modeling
di: Bordel-Vozmediano, Silvia, et al.
Pubblicazione: (2025)

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy
di: Gloria Iacoboni, et al.
Pubblicazione: (2024)

Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study
di: Mariana Bastos‐Oreiro, et al.
Pubblicazione: (2025)

The CAR T‐cell race: The rules of the game
di: Adriana Balduzzi
Pubblicazione: (2024)

Safety and promising efficacy with enhanced CAR T‐cell therapy for lymphoma
di: Mary Beth Nierengarten
Pubblicazione: (2025)

Tandem combination of ASCT and CAR T‐cell therapy in highly refractory CNS lymphomas
di: Lydia Montes, et al.
Pubblicazione: (2025)

Glycolytic activity following anti‐CD19 CAR‐T cell infusion in non‐Hodgkin lymphoma
di: Nicolas Vallet, et al.
Pubblicazione: (2024)

Improving the safety of CAR‐T‐cell therapy: The risk and prevention of viral infection for patients with relapsed or refractory B‐cell lymphoma undergoing CAR‐T‐cell therapy
di: Hu Qian, et al.
Pubblicazione: (2024)

La eutanasia como antídoto del suicidio
di: José Martín Amenabar Beitia
Pubblicazione: (2019)

A mathematical model for fibrous dysplasia: The role of the flow of mutant cells
di: Soloviova, Mariia, et al.
Pubblicazione: (2024)

Chimeric antigen receptor copies in cell‐free DNA predict relapse in aggressive B‐cell lymphoma patients treated with CAR T‐cell therapy
di: Ismael de la Iglesia‐San Sebastián, et al.
Pubblicazione: (2024)

Early CAR− CD4+ T‐lymphocytes recovery following CAR‐T cell infusion: A worse outcome in diffuse large B cell lymphoma
di: Massimiliano Gambella, et al.
Pubblicazione: (2024)

Impact of the kinetics of circulating anti‐BCMA CAR‐T cells and normal lymphocytes on the outcome of MM patients
di: Sara Gutiérrez‐Herrero, et al.
Pubblicazione: (2025)

Modelling the role of flux density and coating on nanoparticle internalization by tumor cells under centrifugation
di: Calvo, Gabriel F., et al.
Pubblicazione: (2024)

Efficacy and safety of bendamustine‐containing bridging therapy in R/R LBCL patients receiving CD19 CAR T‐cells
di: Gloria Iacoboni, et al.
Pubblicazione: (2024)

Preliminary evidence of CAR T‐cell therapy activity in vitreoretinal lymphomas: An LOC network study
di: Cécile Pivert, et al.
Pubblicazione: (2025)

Clonal haematopoiesis: A common progenitor for cytotoxic peripheral T‐cell lymphoma and angioimmunoblastic T‐cell lymphoma
di: Antonio Vogelsberg, et al.
Pubblicazione: (2024)

Transient imaging changes accompany ‘spinal ICANS ’ following CAR T‐cell therapy for large B‐cell lymphoma in adults
di: Frederick W. Vonberg, et al.
Pubblicazione: (2025)

Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
di: Sophia Stock, et al.
Pubblicazione: (2025)

Folate receptor beta targeting of tumor‐associated macrophages improves lymphoma cell responses to CD19 CAR T cells
di: Kerttu Kalander, et al.
Pubblicazione: (2026)

Decreased renal function predicts severe cytokine release syndrome after CAR ‐T‐cell therapy for large B‐cell lymphoma
di: Yasuyuki Arai, et al.
Pubblicazione: (2026)

Biomarkers of outcome in patients undergoing CD19 CAR‐T therapy for large B cell lymphoma
di: Inna Y. Gong, et al.
Pubblicazione: (2024)

CAR T access and outcomes in large B‐cell lymphoma according to ethnicity and socioeconomic deprivation in the UK
di: Diana Dragoi, et al.
Pubblicazione: (2025)

The challenge of standardizing CAR‐T cell monitoring: A comparison of two flow‐cytometry methods and correlation with qPCR technique
di: Juan Luis Valdivieso‐Shephard, et al.
Pubblicazione: (2024)

Several factors that predict the outcome of large B‐cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T‐cell therapy can be identified before cell administration
di: Alice Sýkorová, et al.
Pubblicazione: (2024)

Outcomes and treatment patterns of patients with primary mediastinal B‐cell lymphoma after CAR‐T cell therapy failure: A DESCAR‐T analysis
di: Jean Galtier, et al.
Pubblicazione: (2025)

Comparison principles for stochastic Volterra equations
di: Cañadas, Ole, et al.
Pubblicazione: (2024)

Cutaneous T‐cell lymphomas initially diagnosed as inflammatory dermatoses and treated with biologics and small molecules
di: Daniel Martín‐Torregrosa, et al.
Pubblicazione: (2025)

Varnimcabtagene autoleucel (ARI‐0001) in relapsed or refractory mantle cell lymphoma
di: Nil Albiol, et al.
Pubblicazione: (2026)

Outcomes of tafasitamab and lenalidomide in large B‐cell lymphoma based on prior CD19‐directed CAR T exposure
di: Mwanasha H. Merrill, et al.
Pubblicazione: (2025)

Efficacy and side effects of anti‐CD19 CAR T‐cell therapy in patients with relapsed/refractory gastrointestinal lymphoma
di: Yi Li Jiang, et al.
Pubblicazione: (2024)

A 24-color flow cytometry panel for functional and phenotypic assessment of armored CAR T-cells in the context of Tumor Microenvironment
di: Gomez, Martin, et al.
Pubblicazione: (2026)

Liquid biopsy for molecular characterization of diffuse large B‐cell lymphoma and early assessment of minimal residual disease
di: Miguel Alcoceba, et al.
Pubblicazione: (2024)

Data from cell lines of the project "Optimisation of PK/PD parameters of a repurposed drug therapy for patients with SMA".
di: Artero, Ruben, et al.
Pubblicazione: (2026)

LOS CIUDADANOS NO NACIONALES Y LOS IMPUESTOS LOCALES. LA ATENCIÓN AL CONTRIBUYENTE EXTRANJERO EN LA PROVINCIA DE ALICANTE (1994-2014)
di: Irene Belmonte Martín
Pubblicazione: (2014)

Tratando de entender la participación política de las mujeres: un análisis descriptivo a partir de un estudio cuantitativo
di: Irene Belmonte Martín
Pubblicazione: (2016)

LA GESTIÓN TRIBUTARIA LOCAL EN ESPAÑA: ALGUNAS PROPUESTAS SOLIDARIAS DEL ESTADO DEL BIENESTAR ANTE LA CRISIS GLOBAL
di: Irene Belmonte Martín
Pubblicazione: (2013)